A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
Public ClinicalTrials.gov record NCT00528372. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to determine whether dapagliflozin can improve (decrease) blood glucose values in patients with Type 2 diabetes who have never been treated with medication or have been taking medication for less than 24 weeks since their original diabetes diagnosis. The safety of this treatment will also be studied.
Study identification
- NCT ID
- NCT00528372
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,067 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 77 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2007 (Type not available)
- Primary completion
- Feb 2009 (Actual)
- Completion
- Jul 2010 (Actual)
- Last update posted
- Oct 20, 2015
2007 – 2010
United States locations
- U.S. sites
- 38
- U.S. states
- 18
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 43rd Medical Associates, P.C. | Phoenix | Arizona | 85051 | — |
| Clin Res Advantage, Inc/East Valley Family Physicians, Plc | Tempe | Arizona | 85282 | — |
| Clinical Research Advantage, Inc | Tempe | Arizona | 85282 | — |
| Valley Research | Fresno | California | 93720 | — |
| Cherlin, Richard | Los Gatos | California | 95032 | — |
| Ritchken & First M.D.'S | San Diego | California | 92117 | — |
| Torrance Clinical Research | Torrance | California | 90717 | — |
| Aurora Family Medicine Center, P.C. | Aurora | Colorado | 80012 | — |
| Expresscare Clinical Research | Colorado Springs | Colorado | 80909 | — |
| Center For Internal Medicine | Denver | Colorado | 80209 | — |
| Denver Internal Medicine Group | Denver | Colorado | 80209 | — |
| Central Florida Clinical Trials | Altamonte Springs | Florida | 32701 | — |
| Family Care Associates | Chipley | Florida | 32428 | — |
| Westside Center For Clinical Research | Jacksonville | Florida | 32205 | — |
| Panhandle Family Care Associates | Marianna | Florida | 32446 | — |
| Louisiana Heart Center | Slidell | Louisiana | 70458 | — |
| Jackson, Danny W. | Rolling Fork | Mississippi | 39159 | — |
| Woodlake Research | Chesterfield | Missouri | 63017 | — |
| Nevada Alliance Against Diabetes | Las Vegas | Nevada | 89101 | — |
| Slocum-Dickson Medical Group, Pllc | New Hartford | New York | 13413 | — |
| Internist Associates Of Central New York, P. C. | Syracuse | New York | 13210 | — |
| Southgate Medical Group | West Seneca | New York | 14224 | — |
| Providence Health Partners | Dayton | Ohio | 45439 | — |
| Newark Physician Associates | Newark | Ohio | 43055 | — |
| Physician Research, Inc. | Zanesville | Ohio | 43701 | — |
| Gilbert Medical Research, Llc | Bethany | Oklahoma | 73008 | — |
| Integris Family Care Yukon | Yukon | Oklahoma | 73109 | — |
| Banksville Medical, Pc | Pittsburgh | Pennsylvania | 15216 | — |
| Southeastern Research Associates, Inc. | Taylors | South Carolina | 29687 | — |
| Holston Medical Group | Kingsport | Tennessee | 37660 | — |
| Village Family Practice | Houston | Texas | 77024 | — |
| Abbott Clinical Research Group, Inc. | San Antonio | Texas | 78224 | — |
| Sam Clinical Research Center | San Antonio | Texas | 78229 | — |
| Taylor/Wade Medical | Bountiful | Utah | 84010 | — |
| Optimum Clinical Research, Inc. | Salt Lake City | Utah | 84102 | — |
| J. Lewis Research, Inc | Salt Lake City | Utah | 84121 | — |
| Tidewater Integrated Medical Research | Virginia Beach | Virginia | 23454 | — |
| William L. Gray, Md | Spokane | Washington | 99216 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00528372, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2015 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00528372 live on ClinicalTrials.gov.